dDepartment of Disease Control and Prevention, Pasteur Institute of Ho Chi Minh City, Ho Chi Minh City, Vietnam ...

aDepartment of Infectious Diseases and Respiratory Medicine, Charité—Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany bInstitute of Virology, ...

Trial targets enrollment of 640 participants aged 50 and over to receive amezosvatein or Shingrix®SEATTLE, June 02, 2025 ...

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID. Please note: If you switch to a different device, you may be ...

Moderna has withdrawn the BLA for mRNA-1083, a combination vaccine against seasonal influenza and SARS-CoV-2, after consulting with FDA.

Reactogenicity and safety of QIV was consistent with TIV. Conclusions QIV provided superior immunogenicity for the alternate-lineage B strain compared with TIV without interfering with immune ...

Messenger RNA (mRNA) vaccines hold promise for creating new and improved immunizations; however, their delivery is challenging in terms of compliance, reactogenicity, cost and scalability.

A two-in-one mRNA vaccine against influenza and COVID-19 showed good reactogenicity and safety results compared with vaccines already on the market. (JAMA) New York reported a record high of 25 ...

(Nasdaq: NVAX) today announced preliminary results from the SHIELD-Utah study (Study of Healthcare Workers and First Responders Investigating Effects of Systemic and Local reactogenicity of COVID ...